PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)

$6.49 -0.1 (-1.5175%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) News Sources

Wall Street Analysts See a 58.42% Upside in Prelude Therapeutics (PRLD): Can the Stock Really Move This High?

31-07-2026

yahoo.com

external link

Sellas’ Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global – Analyst Sees About 200% Upside Potential

12-08-2026

stocktwits.com

external link

Prelude Therapeutics Announces the Appointment of Charles Morris, M.D. as Chief Medical Officer

15-04-2026

yahoo.com

external link

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026

20-04-2026

yahoo.com

external link

Prelude Therapeutics (PRLD) Presents Preclinical Data for KAT6A Degarader PRT13722 in Breast Cancer

01-05-2026

yahoo.com

external link

Wall Street Analysts Think Prelude Therapeutics (PRLD) Could Surge 33.59%: Read This Before Placing a Bet

08-05-2026

yahoo.com

external link

Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

12-05-2026

yahoo.com

external link

Earnings Beat: Prelude Therapeutics Incorporated (NASDAQ:PRLD) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

16-05-2026

yahoo.com

external link

Goldman Sachs Initiates Coverage of Prelude Therapeutics (PRLD)

31-05-2026

yahoo.com

external link

Prelude Therapeutics (PRLD) Upgraded to Buy: Here's Why

17-07-2026

yahoo.com

external link

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) Sentiment Trend

0 25 50 75 100 69 71 85 76 89 55 70 90 93 92 31-07-2026 12-08-2026 15-04-2026 20-04-2026 01-05-2026 08-05-2026 12-05-2026 16-05-2026 31-05-2026 17-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) FAQs

toggle

What is the current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The current price of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is $6.49.


toggle

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) absolute price change since previous trading day?

The absolute price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is $-0.1.


toggle

PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) percentage price change since previous trading day?

The percentage price change of PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) since the previous trading day is -1.5175%.


toggle

What is the most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The most recent average sentiment score for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)?

The most recent sentiment for PRELUDE THERAPEUTICS INC (PRLD:NASDAQ) is .


SEC-8K** Filing Available For PRELUDE THERAPEUTICS INC (PRLD:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

PRME (Prime Medicine Inc)
PRAX (Praxis Precision Medicines Inc)
PRQR (Proqr Therapeutics)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.